Moderna Inc (MRNA)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$25.21

Buy

$25.23

arrow-up$0.97 (+4.00%)

Prices updated at 12 May 2025, 14:58 EDT

Prices minimum 15 mins delay

Prices in USD

NASDAQ

3.58%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Biotechnology

Chairman

Dr. Noubar B. Afeyan, PhD

CEO

Mr. Stephane Bancel

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

5,800

Head office

325 Binney Street

Cambridge

United States

02139

+1 617 714-6500

Lavina.Talukdar@modernatx.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Ms. Elizabeth E. Tallett Independent Director	0.10m
Mr. Paul Sagan Independent Director	0.08m
Dr. Noubar B. Afeyan, PhD Chairman of the Board	0.15m
Mr. Abbas Hussain Independent Director	0.02m
Mr. Stephane Bancel Director and Chief Executive Officer	1.63m
Mr. David M. Rubenstein Independent Director	0.04m
Dr. Elizabeth G. Nabel, M.D. Independent Director	0.10m
Dr. Sandra J. Horning, M.D. Independent Director	0.10m
Mr. James M Mock Chief Financial Officer and Principal Accounting Officer	0.83m
Dr. Stephen Hoge, M.D. President	1.08m
Ms. Shannon Thyme Klinger Chief Legal Officer and Corporate Secretary	0.83m
Dr. Francois Nader, M.D. Independent Director	0.10m
Ms. Tracey Franklin Chief People and Digital Technology Officer	-
Ms. Kate Cronin Chief Brand Officer	-
Dr. Jerh Collins, PhD Chief Technical Operations and Quality Officer	-
Dr. Rose Loughlin, PhD Executive Vice President, Research	-
Dr. Jacqueline Miller, M.D. Chief Medical Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	40,323,750
BlackRock Inc	25,791,947
Baillie Gifford & Co Limited.	24,948,558
FMR Inc	18,664,634
Fidelity Management and Research Company	18,664,634

Director dealings

Date chevron-l-regular chevron-r-regular	Action
06 Dec 2024	-
09 Dec 2024	-
06 Dec 2024	-
05 Dec 2024	-
05 Dec 2024	-
02 Dec 2024	-
03 Dec 2024	-
02 Dec 2024	-
02 Dec 2024	-
03 Dec 2024	-
02 Dec 2024	-
27 Nov 2024	-
27 Nov 2024	-
27 Nov 2024	-
29 Nov 2024	-
27 Nov 2024	-
27 Nov 2024	-
27 Nov 2024	-
27 Nov 2024	-
27 Nov 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.